Magnetic resonance spectroscopy of isocitrate dehydrogenase mutated gliomas: current knowledge on the neurochemical profile

Keyphrases

• Magnetic Resonance Spectroscopy 100%
• Glioma 100%
• Neurochemical Profile 100%
• Isocitrate Dehydrogenase 1 (IDH1) 100%
• 2-Hydroxyglutarate (2-HG) 75%
• Glioma Subtypes 50%
• Disease Progression 25%
• Glutamate 25%
• Patient Outcomes 25%
• Therapeutic Strategies 25%
• Follow-up Examination 25%
• Glutathione 25%
• Patient Management 25%
• Response to Treatment 25%
• Routine Clinical Practice 25%
• Glycine 25%
• Non-invasive Diagnosis 25%
• Metabolic Reprogramming 25%
• Disease Response 25%
• Lactate 25%
• Accurate Diagnosis 25%
• Tumor Treatment 25%
• Specific Identification 25%
• Cystathionine 25%
• Anticancer Treatment 25%
• Isocitrate Dehydrogenase Gene 25%
• Resonance Spectroscopy 25%
• During Treatment 25%
• Neurochemical Alterations 25%

Medicine and Dentistry

• Ganglioglioma 100%
• Isocitrate Dehydrogenase 100%
• NMR Spectroscopy 100%
• 2 Hydroxyglutaric Acid 50%
• Metabolite 50%
• Ex Vivo 16%
• Disease Exacerbation 16%
• Glutamic Acid 16%
• Amino Acid 16%
• Cancer Treatment 16%
• Lactic Acid 16%
• Glutathione 16%
• Cystathionine 16%

Neuroscience

• Glioma 100%
• Nuclear Magnetic Resonance Spectroscopy 100%
• Isocitrate Dehydrogenase 100%
• In Vivo 16%
• Spectroscopy 16%
• Reprogramming 16%
• Glutamic Acid 16%
• Amino Acid 16%
• Glutathione 16%
• Cystathionine 16%